Tiago R. Magalhaes from G42 Healthcare in the United Arab Emirates presented at London Calling 2023 on “The Emirati Genome Project: where long reads became an integral part of large genome projects (a first!). G42 now has hospitals, clinical diagnostics, and a genomics program. Magalhaes noted that the organization has several hospitals. They also spoke […]
Fuchou Tang from the Biomedical Pioneering Innovation Center in Peking University, China, spoke at London Calling 2023 about “scNanoATAC-seq: a long-read single-cell assay to simultaneously detect chromatin accessibility and genetic variants.” Tang spoke about developing single-cell genomics tools as a postdoctoral researcher. Then, in 2013, they developed individual cell methylation tools. Tang and team continued […]
Rachel Thijssen from the Walter and Eliza Hall Institute of Medical Research and Australia & Amsterdam University Medical Centers in the Netherlands presented at London Calling 2023 on “Single-cell long-read RNA sequencing reveals complex heterogeneity.” Thijssen spoke about the hallmarks of cancer and cells not responding to signals appropriately. BCL2 can be targeted in chronic […]
Dan Turner SVP of the Applications Team at Oxford Nanopore Technologies, presented the update from the Apps Team. Turner summarized the use of Nanopore data for clinical whole-genome sequencing of rare diseases and cancer with the goal of identifying relevant variants. Turner explained that although rare diseases are rare by definition, there are over 3,000 […]
Kimberley Billingsley from the NIH Center for Alzheimer’s and Related Dementias (CARD) presented at London Calling 2023 on “Population-scale nanopore sequencing to further understand the genetics of Alzheimer’s disease and related dementias.” They described how the center’s mission is to support research for Alzheimer’s and other diseases. The center begins with genetics research. Billingsley noted […]
Josie Gleeson from The University of Melbourne in Australia presented at London Calling 2023 about “Integrating the transcriptome and epitranscriptome of the human brain using direct RNA sequencing.” They spoke about the advantages of direct RNA sequencing with Oxford Nanopore Technologies: you obtain splicing patterns, isoform quantification, polyA tail length, modified nucleotides, and novel exon/intron […]
Oscar Gonzalez-Recio from the National Institute for Agricultural and Food Research and Technology at the Spanish National Research Council in Spain presented at London Calling 2023 on “(Epi)genotyping by low-pass sequencing using nanopore technologies.” Gonzalez-Recio noted that this worm has been accepted for publication. They started with a history of modern genomic breeding and how […]
Jade Forster from the University of Southampton in the UK presented at London Calling 2023 about “Identifying m6A RNA modifications in neuroblastoma cell lines using nanopore sequencing.” This session was timely as we are doing our first direct RNA sequencing experiment and GridION run! Forster spoke about epitranscriptomics and RNA modifications. They noted that the […]
What a busy day! We tried VolTRAX and Miro library preps today as part of the PORES workshop. We also did DNA extractions, a Miroculus workshop, and lots of moving around. Tonight I watched the London Calling 2023 session entitled “MethPhaser: automated methylation-based haplotype phasing of human genomes with Oxford Nanopore sequencing” with Fritz Sedlazeck […]
Miranda Galey from the University of Washington spoke at London Calling 2023 about “MeOW: genome-wide identification of differentially methylated regions using Oxford Nanopore long-read sequencing data.” Galey explained how long-read sequencing can shorten the time to diagnosis. The noted that methylated nucleotides have different current patterns that can be detected. The advantage of long-read sequencing […]